Monoclonal Antibodies Market Size, Top Players, and Forecast by 2028
Monoclonal Antibodies Market: Strategic Insights
Monoclonal Antibodies Market
-
CAGR (2021 - 2028)11.8% -
Market Size 2021
US$ 111.01 Billion -
Market Size 2028
US$ 243.05 Billion
Market Dynamics
GROWTH DRIVERS
- Growing demand for targeted therapies
- Rising prevalence of chronic diseases
- Advancements in biopharmaceutical research
FUTURE TRENDS
- Increased focus on personalized medicine
- Advancements in antibody-drug conjugates
- Growth in oncology monoclonal antibodies
OPPORTUNITIES
- Expansion in immunotherapy applications
- Development of biosimilar monoclonals
- Demand in autoimmune disease treatment
Key Players
- Novartis AG
- Pfizer Inc
- GlaxoSmithKline plc
- Amgen Inc
- Daiichi Sankyo Company Limited
- F Hoffmann La Roche AG
- AstraZeneca
- Elli Lilly and Company
- Bayer AG
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Source - Human
- Humanized
- Chimeric
- Murine
Production Method - In-Vitro and In-Vivo
Indication - Cancer
- Autoimmune Diseases
- Infectious Diseases
- Inflammatory Diseases
- Microbial Diseases
Application - Therapeutic Applications
- Diagnostic Applications
- Research Applications
Get Free Sample For